Blog >
+ d'info


Dr. Murray Baron Biography

15 April 2019

Senior Investigator, Lady Davis Institute
Chief, Division of Rheumatology, Jewish General Hospital
Director of the Canadian Scleroderma Research Group
Associate Professor of Medicine, McGill University

Dr. Baron’s Publications Indexed on PubMed

Dr. Murray Baron is the chief of the Division of Rheumatology at the Jewish General Hospital, where he has practiced since 1981.  He graduated from McGill University’s Faculty of Medicine and, after stints as a family doctor in Newfoundland and British Columbia, trained in internal medicine at the University of British Columbia and rheumatology at the University of Toronto.  He is an Associate Professor of Medicine at McGill University.

He runs a division with five full-time academic rheumatologists and one part-time rheumatologist, which is similar to the numbers at the McGill University Health Centre, McGill’s other teaching hospital. In the last three years, three new rheumatologists have been hired, including Dr. Marie Hudson who is a full-time academic. Among the other rheumatologists, one has a strong interest in medical education, another in the use of musculoskeletal ultrasound as a diagnostic tool, and
a third in the use of videocapillaroscopy as a clinical and research tool in the rheumatic diseases.  In addition, Dr. Brett Thombs, an academic psychologist from the department of psychiatry, has a cross appointment in rheumatology.

Major Research Activities

Dr. Baron’s primary research interest is in an uncommon rheumatic disease called scleroderma.  In this disease, there is fibrosis of multiple organs leading to severe morbidity and increased mortality.  Because the disease is rare, Dr. Baron has established the Canadian Scleroderma Research Group (CSRG). Over 15 rheumatologists from across Canada see patients once a year and enter a large amount of data into a central database. Biological specimens, such as blood and skin, are also collected.  Research is performed on the data by clinical researchers at McGill and elsewhere, and on the bio-specimens at multiple laboratories that Dr. Baron has brought into his group. 

Since its inception in 2004, over $4.5 million dollars has been brought in from peer review agencies by Dr. Baron and his colleagues in the CSRG. More than 60 articles have been published in the scientific literature since the CSRG was formed.  The CSRG, under Dr. Baron’s direction, has become a well recognized leader in scleroderma research in the world.

In addition, Dr. Baron has established the McGill Early Arthritis Registry that has performed research on recent onset inflammatory arthritis.  Much of the work in this area will be turned over to one of the new rheumatology recruits, Dr. Sabrina Fallavollita.

He has also created CANCoRC, the Canadian Consortium of Rheumatology Cohorts, in an attempt to strengthen Canadian rheumatology research by seeking common funding and identifying commonalities across rheumatic disease research teams.

Recent Publications

Schieir O, Thombs BD, Hudson M, Boivin JF, Steele R, Bernatsky S, Hanley J, Baron M. Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis. Arthritis Care Res (Hoboken) 2010;62:409-17.

Fan X, Pope J, Baron M. What is the relationship between disease activity, severity and damage in a large Canadian systemic sclerosis cohort? Results from the Canadian Scleroderma Research Group (CSRG). Rheumatol Int 2010;Sep 24. 2009 [Epub ahead of print].

Baron M, Bernier P, Côté L, DeLegge M, Falovitch G, Friedman G, Gornitsky M, Hoffer J, Hudson M, Khanna D, Paterson W, Schafer D, Toskes P. Screening and Therapy for Malnutrition and Related Gastro-Intestinal Disorders in Systemic Sclerosis: Recommendations of a North American Expert Panel. Clin Exp Rheumatol 2010;In Press.

Scleroderma Quebec raises $ 240 000 for research and patient support

15 November 2016

For immediate release

Montreal, November 1st, 2016 – Scleroderma Quebec raised more than $ 240 000 during its benefit evening which was held at Montreal’s Cabaret du Casino on November 1st. The funds will be used to support patients who have scleroderma and to finance the research required to find a cure.  The event was organized under the Honorary Presidency of Mr. François Armand, RBC Royal Bank’s Regional Vice-President of Commercial Financial Services, Quebec Branch.  About 500 people attended the dinner-show starring Robert Charlebois who came back one more time this year by popular demand.

Nutrition and Recipe Book

15 November 2016

Nutrition and recipe book for people with scleroderma

It can be a challenge to know what to eat for the betterment of one’s health.  This is particularly true for those affected by the numerous symptoms of scleroderma.

Here’s a practical guide that is exclusive to Scleroderma Quebec!  It is written by Mrs. Audrey Potvin, a dietetic technician and coordinator for Scleroderma Quebec’s support network.  The guide brings together informative texts about different scleroderma symptoms and contains more than thirty healthy recipes that relate to each theme touched on.  A delicious way to improve your quality of life by enjoying simple and healthy food!

If you would like to order a copy in either English or French at a cost of $30 (including postage), please contact Mrs. Audrey Potvin by email:

Warm regards,

The Scleroderma Quebec Team

Scleroderma Support Group Survey

23 April 2015

Do you have scleroderma? Are you interested in helping advance research on scleroderma support groups? If so, please lend a hand by completing this short 10-15 minute survey!  (more…)

New drug approved for the treatment of pulmonary arterial hypertension

4 December 2014

Pulmonary arterial hypertension (PAH) is a common, serious complication of Scleroderma which can quickly lead to death if left untreated. Opsumit® (macitentan), a new treatment option, was shown to be effective in reducing morbidity and mortality in adult patients with PAH. (more…)